|
7:50 AM
|
Welcome and Announcements
Lars Svensson, MD, PhD
|
Session I – Prevention and Management
Moderator: Leslie Cho, MD
|
|
8:00 AM
|
Imaging for risk stratification and primary prevention: current and emerging concepts
Milind Desai, MD, MBA
|
|
8:15 AM
|
Modern Lipid Management: New Therapies, When to Treat, and How to Initiate
Leslie Cho, MD
|
|
8:30 AM
|
GLP-1 Receptor Agonists and SGLT2 Inhibitors for Type 2 Diabetes, Obesity, and Metabolic Syndrome: New Insights and Opportunities for Cardiovascular Protection
Dennis Bruemmer, MD, PhD
|
|
8:45 AM
|
Hypertension: an old disease with new treatment options
Leslie Cho, MD
|
|
9:00 AM
|
Panel Discussion & Attendee Q&A
Session Faculty
|
|
9:20 AM
|
Refreshments & Exhibit Break
|
Session II – Coronary Artery Disease
Moderator: Milind Desai, MD, MBA
|
|
9:40 AM
|
Decision Making in Coronary Chronic Total Occlusions
Jaikirshan Khatri, MD
|
|
9:55 AM
|
Diagnosis and management of microvascular disease
Khaled Ziada, MD
|
|
10:10 AM
|
Management and Outcomes in CABG for Complex Multivessel Disease
Faisal Bakaeen, MD
|
|
10:25 AM
|
Panel Discussion & Attendee Q&A
Session Faculty
|
Session III – Mitral and Tricuspid Valve
Moderator: Brian Griffin, MD
|
|
10:40 AM
|
Degenerative MR: Clinical Assessment, Evaluation and Timing of Intervention
Brian Griffin, MD
|
|
10:55 AM
|
Functional/secondary MR: Diagnosis and Role of GDMT
Randall Starling, MD, MPH
|
|
11:10 AM
|
Management of Tricuspid Disease- Current and Future Options
Amar Krishnaswamy, MD
|
|
11:25 AM
|
Current Status of Transcatheter Mitral Valve Therapies
Samir Kapadia, MD
|
|
11:40 AM
|
Surgical Techniques for Primary MR: From Resection to Preservation to Robotic
Daniel Burns, MD
|
|
11:55 AM
|
Panel Discussion & Attendee Q&A
Session Faculty
|
|
12:15 PM
|
Lunch
|
Session IV – Aortic Valve
Moderator: Amar Krishnaswamy, MD
|
|
1:00 PM
|
Patient Selection and Shared Decision Making in patients with Aortic Valve Disease
Amar Krishnaswamy, MD
|
|
1:15 PM
|
Contemporary Trends in AS Management
Brian Griffin, MD
|
|
1:30 PM
|
Update on TAVR: Indications, Outcomes/Durability, Complications
Samir Kapadia, MD
|
|
1:45 PM
|
The Benefit of Surgical Intervention in Low Flow, Low Gradient AS
Daniel Burns, MD
|
|
2:00 PM
|
Panel Discussion & Attendee Q&A
Session Faculty
|
|
2:20 PM
|
Exhibit Break
|
Session V – EP
Moderator: Mohamed Kanj, MD
|
|
2:35 PM
|
Risk Factors for AF and How do I work up a Patient who has New Onset Atrial Fibrillation?
Shady Nakhla, MD
|
|
2:50 PM
|
Medical and Interventional Options for Stroke Risk in AF: LAAC Updates
Mohamed Kanj, MD
|
|
3:05 PM
|
Ventricular Premature Complexes – From Benign to Malignant When to Worry?
Mohamed Kanj, MD
|
|
3:20 PM
|
Panel Discussion & Attendee Q&A
Session Faculty
|
Session VI – Heart Failure and Cardiomyopathy
Moderator: Randall Starling, MD, MPH
|
|
3:35 PM
|
HFrEF: Essentials of Guideline Directed Medical Therapy
Randall Starling, MD, MPH
|
|
3:50 PM
|
Evaluating and Managing HFpEF
Sanjeeb Bhattacharya, MD
|
|
4:05 PM
|
Hypertrophic Cardiomyopathy: Diagnosis and Management
Milind Desai, MD, MBA
|
|
4:20 PM
|
Selection, Strategies and Decision Making in Temporary and Long Term Mechanical Circulatory Support and Transplant
Michael Zhen-Yu Tong, MD, MBA
|
|
4:45 PM
|
Panel Discussion & Attendee Q&A
Session Faculty
|
|
5:00 PM
|
Adjourn
|
